<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>iPump, Inc. &#187; fda alerts</title>
	<atom:link href="http://www.ipump.org/blog/tag/fda-alerts/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.ipump.org/blog</link>
	<description>a (501(c)(3) charity with a heart</description>
	<lastBuildDate>Thu, 10 Feb 2011 16:58:59 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.9.1</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>FDA Early Communication About the Safety of Lantus (Insulin Glargine)</title>
		<link>http://www.ipump.org/blog/2009/07/08/fda-early-communication-about-the-safety-of-lantus-insulin-glargine/</link>
		<comments>http://www.ipump.org/blog/2009/07/08/fda-early-communication-about-the-safety-of-lantus-insulin-glargine/#comments</comments>
		<pubDate>Thu, 09 Jul 2009 02:09:07 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[FDA Alerts, Recalls, Product Safety]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[fad advisory]]></category>
		<category><![CDATA[fda alerts]]></category>
		<category><![CDATA[insulin glargine]]></category>
		<category><![CDATA[lantus]]></category>

		<guid isPermaLink="false">http://www.ipump.org/blog/?p=43</guid>
		<description><![CDATA[FDA is aware of four recently-published observational studies that looked at the use of Lantus (insulin glargine) and possible risk for cancer in patients with diabetes. Three of the four studies suggest an increased risk for cancer associated with use of Lantus.]]></description>
		<wfw:commentRss>http://www.ipump.org/blog/2009/07/08/fda-early-communication-about-the-safety-of-lantus-insulin-glargine/feed/</wfw:commentRss>
		<slash:comments>3</slash:comments>
		</item>
		<item>
		<title>BYETTA May Be Causing Pancreatitis and Death</title>
		<link>http://www.ipump.org/blog/2007/10/16/byetta-may-be-causing-pancreatitis-and-death/</link>
		<comments>http://www.ipump.org/blog/2007/10/16/byetta-may-be-causing-pancreatitis-and-death/#comments</comments>
		<pubDate>Wed, 17 Oct 2007 02:43:56 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[FDA Alerts, Recalls, Product Safety]]></category>
		<category><![CDATA[byetta]]></category>
		<category><![CDATA[fda alerts]]></category>

		<guid isPermaLink="false">http://www.ipump.org/blog/?p=50</guid>
		<description><![CDATA[October 16, 2007
For those who may be using BYETTA (which may be prescribed for PCOS, pre-diabetes, type 2, or LADA) the FDA has issued warnings about patients using BYETTA developing pancreatitis.
Read more on WebMD
Exenatide (marketed as Byetta)
FDA ALERT [10/2007]:  FDA has reviewed 30 postmarketing reports of acute pancreatitis in patients taking Byetta, a drug used [...]]]></description>
		<wfw:commentRss>http://www.ipump.org/blog/2007/10/16/byetta-may-be-causing-pancreatitis-and-death/feed/</wfw:commentRss>
		<slash:comments>1</slash:comments>
		</item>
	</channel>
</rss>

